Earlier this month, PPMD and other advocacy organizations joined 180 U.S. Representatives and 54 U.S. Senators to request the removal of language included in the Senate version of the National Defense Authorization Act (NDAA) that would have a detrimental impact on research at the Congressionally-Directed Medical Research Program (CDMRP) at the U.S. Department of Defense (DoD). Following months…